(MedPage Today) — BERLIN — Patients with cisplatin-ineligible bladder cancer had huge reductions in clinical events and cancer death when treated with a novel combination therapy before and after surgery, according to a randomized trial reported…
Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118024
Author :
Publish date : 2025-10-19 21:33:00
Copyright for syndicated content belongs to the linked Source.
